Vaping vs Smoking: What Australian Research Says

Vaping vs Smoking: What Does Australian Research Tell Us?

The debate around vaping versus smoking continues to be one of the most discussed topics in Australian public health. As vaping has grown in popularity across Australia, with vape shops now present in virtually every city and town, understanding what the research says about the relative risks and benefits has become increasingly important. This article examines the current evidence from Australian and international research to provide a balanced, informative overview.

Understanding the Basics

Before examining the research, it is important to understand the fundamental differences between vaping and smoking. Traditional cigarettes burn tobacco, producing smoke that contains thousands of chemicals, many of which are known carcinogens. Vaping, by contrast, heats an e-liquid to produce an aerosol (commonly called vapour) without combustion. This distinction is central to the harm reduction argument that has shaped much of the research in this field.

E-liquids used in devices sold at Australian vape shops typically contain a base of propylene glycol and vegetable glycerine, flavourings, and optionally nicotine. The absence of combustion means that many of the harmful chemicals found in cigarette smoke are either absent or present at significantly reduced levels in vape aerosol.

Australian Research and Positions

The Royal Australian College of General Practitioners

The RACGP has acknowledged that e-cigarettes may have a role in smoking cessation for adults who have been unable to quit through other methods. Their position recognises the relative harm reduction potential of vaping compared to continued smoking, while also emphasising the importance of evidence-based prescribing and monitoring.

Australian National University Studies

Researchers at the Australian National University have conducted studies examining the chemical composition of vape aerosol compared to cigarette smoke. Their findings have generally confirmed international research showing significantly lower levels of toxic compounds in vape aerosol compared to cigarette smoke. These studies contribute to the growing body of evidence supporting the harm reduction potential of vaping for adult smokers.

The TGA's Position

The Therapeutic Goods Administration has taken a cautious approach to vaping, regulating nicotine-containing e-cigarettes as therapeutic goods. The TGA acknowledges that while vaping is not risk-free, it is generally considered to be less harmful than smoking traditional cigarettes. Their regulatory framework aims to ensure that vaping products meet quality and safety standards while remaining accessible to adult smokers who wish to transition away from cigarettes.

International Evidence

Public Health England and UK Research

One of the most frequently cited findings in the vaping versus smoking debate comes from Public Health England (now the Office for Health Improvement and Disparities), which published a landmark review concluding that vaping is estimated to be around 95 percent less harmful than smoking. This figure, while debated, has been supported by subsequent reviews and has influenced harm reduction policies in the UK and other countries.

Cochrane Reviews

The Cochrane Library, widely regarded as the gold standard for systematic reviews of healthcare interventions, has published reviews on e-cigarettes for smoking cessation. Their analyses of randomised controlled trials have found evidence that nicotine e-cigarettes can help people quit smoking, with quit rates comparable to or exceeding those achieved with traditional nicotine replacement therapies.

Key Areas of Research

Respiratory Health

Research from multiple Australian and international institutions has examined the respiratory effects of vaping compared to smoking. Studies consistently show that smokers who switch completely to vaping experience improvements in respiratory function, reduced coughing, and decreased phlegm production. However, researchers note that vaping is not without risk and that long-term studies spanning decades are still needed.

Cardiovascular Health

Emerging research suggests that the cardiovascular risks associated with vaping are lower than those associated with smoking. While nicotine itself has cardiovascular effects, the absence of combustion products in vape aerosol appears to reduce the overall cardiovascular burden compared to cigarette smoking. Australian researchers continue to study these effects in the local population.

Cancer Risk

The majority of carcinogens found in cigarette smoke result from the combustion process. Since vaping does not involve combustion, the levels of known carcinogens in vape aerosol are significantly lower. While long-term cancer risk data for vaping specifically is not yet available due to the relative newness of the technology, the chemical analysis suggests a substantially reduced risk profile compared to smoking.

What This Means for Australian Vapers

• The scientific consensus supports vaping as a less harmful alternative to smoking for adult smokers.
• Vaping is not risk-free and is not recommended for non-smokers or young people.
• Smokers who switch completely to vaping are likely to experience health improvements.
• Using products from reputable Australian vape shops helps ensure product quality and safety.
• Ongoing research continues to refine our understanding of the long-term effects of vaping.

Conclusion

The body of Australian and international research increasingly supports vaping as a significantly less harmful alternative to smoking for adult smokers. While the science continues to evolve and long-term data is still being collected, the current evidence provides a strong basis for harm reduction approaches. Australian vapers who purchase quality products from reputable vape shops and use them as intended can take confidence in the growing body of evidence supporting the relative safety of vaping compared to continued smoking.